140 related articles for article (PubMed ID: 32581060)
1. Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens.
Arribillaga L; Echeverria I; Belsue V; Gomez T; Lozano T; Casares N; Villanueva L; Domingos-Pereira S; Romero PJ; Nardelli-Haefliger D; Hervás-Stubbs S; Sarobe P; Rodriguez MJ; Carrascosa JL; Zürcher T; Lasarte JJ
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581060
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of a multi-epitope DNA vaccine against HPV16.
Zhu L; Cui X; Yan Z; Tao Y; Shi L; Zhang X; Yao Y; Shi L
Hum Vaccin Immunother; 2024 Dec; 20(1):2352908. PubMed ID: 38780076
[TBL] [Abstract][Full Text] [Related]
3. Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.
Báez-Astúa A; Herráez-Hernández E; Garbi N; Pasolli HA; Juárez V; Zur Hausen H; Cid-Arregui A
J Virol; 2005 Oct; 79(20):12807-17. PubMed ID: 16188983
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.
Zhao L; Liu B; Ren J; Feng J; Pang Z; Gao J; Zhang H; Tan W; Tian H; Ruan L
Virol J; 2011 Jun; 8():302. PubMed ID: 21672263
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein.
Liu H; Wu BH; Rowse GJ; Emtage PC
Clin Vaccine Immunol; 2007 Aug; 14(8):1013-23. PubMed ID: 17596433
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.
Soong RS; Song L; Trieu J; Knoff J; He L; Tsai YC; Huh W; Chang YN; Cheng WF; Roden RB; Wu TC; Trimble CL; Hung CF
Clin Cancer Res; 2014 Nov; 20(21):5456-67. PubMed ID: 24893628
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1.
Garcia-Bates TM; Kim E; Concha-Benavente F; Trivedi S; Mailliard RB; Gambotto A; Ferris RL
J Immunol; 2016 Mar; 196(6):2870-8. PubMed ID: 26851223
[TBL] [Abstract][Full Text] [Related]
8. Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara.
Mackova J; Stasikova J; Kutinova L; Masin J; Hainz P; Simsova M; Gabriel P; Sebo P; Nemeckova S
Cancer Immunol Immunother; 2006 Jan; 55(1):39-46. PubMed ID: 15926077
[TBL] [Abstract][Full Text] [Related]
9. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy.
Al-Taei S; Banner R; Powell N; Evans M; Palaniappan N; Tabi Z; Man S
Cancer Immunol Immunother; 2013 Dec; 62(12):1821-30. PubMed ID: 24146146
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of HPV-related cancer through a mRNA vaccine expressing APC-targeting antigen.
Li X; Wang H; Lai W; Liao J; Mo W; Huang K; He L; Liang X; Yu Z; Xu J; Hua X; Hou F; Ding J; Jia WW; Zhang K; Wang Y
Immunology; 2024 Jul; 172(3):375-391. PubMed ID: 38471664
[TBL] [Abstract][Full Text] [Related]
11. Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model.
Silva JR; Sales NS; Silva MO; Aps LRMM; Moreno ACR; Rodrigues EG; Ferreira LCS; Diniz MO
Cancer Immunol Immunother; 2019 May; 68(5):753-763. PubMed ID: 30806747
[TBL] [Abstract][Full Text] [Related]
12. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.
Phaëton R; Gutierrez J; Jiang Z; Karabakhtsian RG; Albanese J; Sunkara J; Fisher DR; Goldberg GL; Dadachova E
Immunotherapy; 2015; 7(6):631-40. PubMed ID: 26098137
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice.
Gomez-Gutierrez JG; Elpek KG; Montes de Oca-Luna R; Shirwan H; Sam Zhou H; McMasters KM
Cancer Immunol Immunother; 2007 Jul; 56(7):997-1007. PubMed ID: 17146630
[TBL] [Abstract][Full Text] [Related]
14. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid.
Chen W; Yan W; Huang L
Cancer Immunol Immunother; 2008 Apr; 57(4):517-30. PubMed ID: 17724588
[TBL] [Abstract][Full Text] [Related]
15. Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer.
Che Y; Yang Y; Suo J; An Y; Wang X
Cancer Immunol Immunother; 2020 Dec; 69(12):2651-2664. PubMed ID: 32607768
[TBL] [Abstract][Full Text] [Related]
16. Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model.
Cui Z; Qiu F
Cancer Immunol Immunother; 2006 Oct; 55(10):1267-79. PubMed ID: 16362407
[TBL] [Abstract][Full Text] [Related]
17. Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.
Dominiecki ME; Beatty GL; Pan ZK; Neeson P; Paterson Y
Cancer Immunol Immunother; 2005 May; 54(5):477-88. PubMed ID: 15750832
[TBL] [Abstract][Full Text] [Related]
18. CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice.
Hansen J; Lindenstrøm T; Lindberg-Levin J; Aagaard C; Andersen P; Agger EM
Cancer Immunol Immunother; 2012 Jun; 61(6):893-903. PubMed ID: 22095092
[TBL] [Abstract][Full Text] [Related]
19. Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation.
Sun Y; Peng S; Yang A; Farmer E; Wu TC; Hung CF
Gene Ther; 2017 Jul; 24(7):408-415. PubMed ID: 28492521
[TBL] [Abstract][Full Text] [Related]
20. The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors.
Moreno ACR; Porchia BFMM; Pagni RL; Souza PDC; Pegoraro R; Rodrigues KB; Barros TB; Aps LRMM; de Araújo EF; Calich VLG; Ferreira LCS
Front Immunol; 2018; 9():1914. PubMed ID: 30186285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
